Octenidine/prednicarbateAlternative Names: LAS 189961/LAS 189962; LAS 189962/LAS 189961; LAS-41003; Prednicarbate/octenidine
Latest Information Update: 25 Mar 2017
At a glance
- Originator Laboratorios Almirall
- Developer Almirall S.A.
- Class Anti-inflammatories; Antifungals; Antiseptics; Glucocorticoids; Skin disorder therapies
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Candidiasis; Eczema; Tinea pedis